Drug Side Effects
Search
SECONDARY CEREBELLAR DEGENERATION
SECONDARY CEREBELLAR DEGENERATION
was reported 62 times
SECONDARY CEREBELLAR DEGENERATION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Microtubule Inhibitor [EPC]
25
0.0002
1
Programmed Death Ligand-1 Blocker [EPC]
3
0.0001
2
HER2/neu Receptor Antagonist [EPC]
10
0.0001
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
11
0.0001
4
Platinum-based Drug [EPC]
25
0.0001
5
Vascular Endothelial Growth Factor Inhibitor [EPC]
9
0.0000
6
Human Immunoglobulin G [EPC]
1
0.0000
7
Bile Acid [EPC]
1
0.0000
8
Topoisomerase Inhibitor [EPC]
3
0.0000
9
Estrogen Receptor Antagonist [EPC]
1
0.0000
10
Interleukin-23 Antagonist [EPC]
1
0.0000
11
Histamine-2 Receptor Antagonist [EPC]
1
0.0000
12
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
13
Kinase Inhibitor [EPC]
3
0.0000
14
Corticosteroid [EPC]
6
0.0000
15
Alkylating Drug [EPC]
1
0.0000
16
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
17
Tumor Necrosis Factor Blocker [EPC]
3
0.0000
18
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
20
Platelet Aggregation Inhibitor [EPC]
1
0.0000
21
Proton Pump Inhibitor [EPC]
1
0.0000
22
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000